Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	MDPI AG 2020-12-01
श्रृंखला:	Vaccines
विषय:	RNA vaccines mRNA vaccines saRNA vaccines pandemic-response vaccine production COVID-19 production process modelling
ऑनलाइन पहुंच:	https://www.mdpi.com/2076-393X/9/1/3

समान संसाधन

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
द्वारा: Robin John Shattock, और अन्य
प्रकाशित: (2023-11-01)

Vaccines’ New Era-RNA Vaccine
द्वारा: Wenshuo Zhou, और अन्य
प्रकाशित: (2023-08-01)

Advancing mRNA technologies for therapies and vaccines: An African context
द्वारा: Dylan Kairuz, और अन्य
प्रकाशित: (2022-10-01)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
द्वारा: Bruna Aparecida Souza Machado, और अन्य
प्रकाशित: (2021-11-01)

Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
द्वारा: Janne Snoeck, और अन्य
प्रकाशित: (2023-11-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
द्वारा: Reese Jalal Ladak, और अन्य
प्रकाशित: (2022-05-01)

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
द्वारा: Yalan Liu, और अन्य
प्रकाशित: (2023-06-01)

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
द्वारा: Alexey D. Perenkov, और अन्य
प्रकाशित: (2023-10-01)

Editorial: RNA vaccines for prevalent and newly emerging diseases
द्वारा: César López-Camacho, और अन्य
प्रकाशित: (2024-08-01)

Development of mRNA rabies vaccines
द्वारा: Zixin Fang, और अन्य
प्रकाशित: (2024-12-01)

A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice
द्वारा: Paul K. Kitandwe, और अन्य
प्रकाशित: (2024-09-01)

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines
द्वारा: Dylan Kairuz, और अन्य
प्रकाशित: (2023-04-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
द्वारा: Min Tang, और अन्य
प्रकाशित: (2023-04-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
द्वारा: Ziqi Cheng, और अन्य
प्रकाशित: (2024-12-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
द्वारा: Karuna M. Das, और अन्य
प्रकाशित: (2022-04-01)

RNA-based vaccines – types, strategies of delivery and overview of RNA vaccines
द्वारा: Barbara Rusinowska, और अन्य
प्रकाशित: (2022-08-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
द्वारा: Qi Ma, और अन्य
प्रकाशित: (2025-01-01)

An mRNA vaccine against rabies provides strong and durable protection in mice
द्वारा: Miao Li, और अन्य
प्रकाशित: (2023-10-01)

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
द्वारा: Shehzad M. Iqbal, और अन्य
प्रकाशित: (2024-08-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
द्वारा: Amparo L. Figueroa, और अन्य
प्रकाशित: (2025-12-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
द्वारा: Alireza Shariati, और अन्य
प्रकाशित: (2024-12-01)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
द्वारा: Chiranjib Chakraborty, और अन्य
प्रकाशित: (2021-07-01)

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
द्वारा: Mohammad Natami, और अन्य
प्रकाशित: (2024-03-01)

Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
द्वारा: Enikő Bárczi, और अन्य
प्रकाशित: (2022-08-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
द्वारा: Albert Liu, और अन्य
प्रकाशित: (2022-07-01)

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines
द्वारा: Teresa Aydillo, और अन्य
प्रकाशित: (2024-12-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
द्वारा: Girolamo Giannotta, और अन्य
प्रकाशित: (2023-03-01)

Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
द्वारा: Emanuele Amodio, और अन्य
प्रकाशित: (2022-03-01)

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development
द्वारा: Emma N. Welbourne, और अन्य
प्रकाशित: (2024-03-01)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
द्वारा: Andrei A. Deviatkin, और अन्य
प्रकाशित: (2022-04-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
द्वारा: Md. Motiar Rahman, और अन्य
प्रकाशित: (2021-03-01)

Editorial: Building public confidence in innovative mRNA vaccines
द्वारा: Jia Hu, और अन्य
प्रकाशित: (2025-01-01)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
द्वारा: Vivek P. Chavda, और अन्य
प्रकाशित: (2023-02-01)

Advances in nucleic acid-based cancer vaccines
द्वारा: Hung-Chun Liao, और अन्य
प्रकाशित: (2025-01-01)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
द्वारा: Yu-Jing Fan, और अन्य
प्रकाशित: (2021-09-01)

A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals
द्वारा: Ann Lisa Arulappen, और अन्य
प्रकाशित: (2022-05-01)

Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
द्वारा: Zoltán Kis
प्रकाशित: (2022-02-01)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
द्वारा: Dimitri Papukashvili, और अन्य
प्रकाशित: (2022-10-01)

Dendrimer-Mediated Delivery of DNA and RNA Vaccines
द्वारा: Lyubov A. Kisakova, और अन्य
प्रकाशित: (2023-03-01)

mRNA Technology and Mucosal Immunization
द्वारा: Antonio Toniolo, और अन्य
प्रकाशित: (2024-06-01)